» Articles » PMID: 38893260

Magnetic Resonance Spectroscopy for Cervical Cancer: Review and Potential Prognostic Applications

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2024 Jun 19
PMID 38893260
Authors
Affiliations
Soon will be listed here.
Abstract

This review article investigates the utilization of MRS in the setting of cervical cancer. A variety of different techniques have been used in this space including single-voxel techniques such as point-resolved spectroscopy (PRESS) and stimulated echo acquisition mode spectroscopy (STEAM). Furthermore, the experimental parameters for these acquisitions including field strength, repetition times (TR), and echo times (TE) vary greatly. This study critically examines eleven MRS studies that focus on cervical cancer. Out of the eleven studies, ten studies utilized PRESS acquisition, while the remaining study used STEAM acquisition. These studies generally showed that the choline signal is altered in cervical cancer (4/11 studies), the lipid signal is generally increased in cervical cancer or the lipid distribution is changed (5/11 studies), and that diffusion-weighted imaging (DWI) can quantitatively detect lower apparent diffusion coefficient (ADC) values in cervical cancer (2/11 studies). Two studies also investigated the role of MRS for monitoring treatment response and demonstrated mixed results regarding choline signal, and one of these studies showed increased lipid signal for non-responders. There are several new MRS technologies that have yet to be implemented for cervical cancer including advanced spectroscopic imaging and artificial intelligence, and those technologies are also discussed in the article.

Citing Articles

Role of Magnetic Resonance Spectroscopy in Evaluating Choline Levels in Gallbladder Carcinoma: A Comprehensive Review.

Kumari A, Mishra G, Parihar P, Dudhe S Cureus. 2024; 16(8):e66205.

PMID: 39233932 PMC: 11374109. DOI: 10.7759/cureus.66205.

References
1.
Barker P, Hearshen D, Boska M . Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med. 2001; 45(5):765-9. DOI: 10.1002/mrm.1104. View

2.
Hwang J, Choi C . Use of in vivo magnetic resonance spectroscopy for studying metabolic diseases. Exp Mol Med. 2015; 47:e139. PMC: 4346484. DOI: 10.1038/emm.2014.101. View

3.
Wilson N, Iqbal Z, Burns B, Keller M, Thomas M . Accelerated five-dimensional echo planar J-resolved spectroscopic imaging: Implementation and pilot validation in human brain. Magn Reson Med. 2015; 75(1):42-51. DOI: 10.1002/mrm.25605. View

4.
Ino H, Honda S, Yamada K, Horita N, Tsugawa S, Yoshida K . Glutamatergic Neurometabolite Levels in Bipolar Disorder: A Systematic Review and Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023; 8(2):140-150. DOI: 10.1016/j.bpsc.2022.09.017. View

5.
Dolciami M, Canese R, Testa C, Pernazza A, Santangelo G, Palaia I . The contribution of the H-MRS lipid signal to cervical cancer prognosis: a preliminary study. Eur Radiol Exp. 2022; 6(1):47. PMC: 9527268. DOI: 10.1186/s41747-022-00300-1. View